perindopril has been researched along with Acute Confusional Senile Dementia in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Abo-Youssef, AM; Ali, MRA; Khattab, MM; Messiha, BAS | 1 |
Abo-Youssef, AM; Ali, MR; Khattab, MM; Messiha, BA | 1 |
Bao, J; Chen, K; Hou, DR; Song, Z; Tian, Y; Wang, Y; Yang, QD; Zhou, L | 1 |
Kanda, T; Nagata, Y; Shirakura, S; Suzuki, N; Takahashi, S; Takayama, M; Uchida, S; Yamada, K | 1 |
Dong, YF; Kataoka, K; Kim-Mitsuyama, S; Koibuchi, N; Nakamura, T; Nako, H; Ogawa, H; Sueta, D; Tokutomi, Y; Toyama, K; Yamamoto, E | 1 |
5 other study(ies) available for perindopril and Acute Confusional Senile Dementia
Article | Year |
---|---|
Perindopril ameliorates experimental Alzheimer's disease progression: role of amyloid β degradation, central estrogen receptor and hyperlipidemic-lipid raft signaling.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Angiotensin-Converting Enzyme Inhibitors; Animals; Cognitive Dysfunction; Disease Models, Animal; Disease Progression; Female; Hyperlipidemias; Insulysin; Membrane Microdomains; Neprilysin; Perindopril; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Signal Transduction | 2020 |
Tempol and perindopril protect against lipopolysaccharide-induced cognition impairment and amyloidogenesis by modulating brain-derived neurotropic factor, neuroinflammation and oxido-nitrosative stress.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Behavior, Animal; Biomarkers; Brain; Brain-Derived Neurotrophic Factor; Cognition; Cognition Disorders; Cyclic N-Oxides; Disease Models, Animal; Inflammation Mediators; Lipopolysaccharides; Male; Maze Learning; Mice, Inbred BALB C; Motor Activity; Neuroprotective Agents; Oxidative Stress; Perindopril; Reactive Nitrogen Species; Recognition, Psychology; Spatial Memory; Spin Labels; Time Factors | 2016 |
Altered angiotensin-converting enzyme and its effects on the brain in a rat model of Alzheimer disease.
Topics: Alzheimer Disease; Angiotensin-Converting Enzyme Inhibitors; Animals; Brain; Disease Models, Animal; Maze Learning; Neurons; Peptidyl-Dipeptidase A; Perindopril; Random Allocation; Rats; Rats, Sprague-Dawley | 2008 |
Effect of a centrally active angiotensin-converting enzyme inhibitor, perindopril, on cognitive performance in a mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Angiotensin-Converting Enzyme Inhibitors; Animals; Behavior, Animal; Cognition; Disease Models, Animal; Enalapril; Exploratory Behavior; Humans; Imidazolidines; Memory; Memory, Long-Term; Mice; Peptidyl-Dipeptidase A; Perindopril; Recognition, Psychology | 2010 |
Perindopril, a centrally active angiotensin-converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Angiotensin-Converting Enzyme Inhibitors; Animals; Astrocytes; Disease Models, Animal; Enalapril; Hippocampus; Imidazolidines; Mice; Mice, Inbred ICR; Mice, Transgenic; Microglia; Nitric Oxide Synthase Type II; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A; Perindopril; Superoxide Dismutase | 2011 |